These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10573109)

  • 1. Immunohistochemical labelling for prostate-specific antigen in breast carcinomas.
    Alanen KA; Kuopio T; Collan YU; Kronqvist P; Juntti L; Nevalainen TJ
    Breast Cancer Res Treat; 1999 Jul; 56(2):169-76. PubMed ID: 10573109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis of prostate-specific antigen in female breast cancer.
    Ilvan S; Celik V; Cetinaslan I; Calay Z; Ferahman M
    J BUON; 2004; 9(2):183-6. PubMed ID: 17415812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate-specific antigen value as a marker in breast cancer.
    Narita D; Cimpean AM; Anghel A; Raica M
    Neoplasma; 2006; 53(2):161-7. PubMed ID: 16575473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical localization of prostate-specific antigen in benign and malignant breast conditions.
    Nariţa D; Raica M; Anghel A; Suciu C; Cîmpean A
    Rom J Morphol Embryol; 2005; 46(1):41-5. PubMed ID: 16286983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of prostate-specific antigen for women with breast cancer: a large United States cohort study.
    Yu H; Levesque MA; Clark GM; Diamandis EP
    Clin Cancer Res; 1998 Jun; 4(6):1489-97. PubMed ID: 9626467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical labelling for prostate specific antigen in non-prostatic tissues.
    Alanen KA; Kuopio T; Koskinen PJ; Nevalainen TJ
    Pathol Res Pract; 1996 Mar; 192(3):233-7. PubMed ID: 8739470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of prostate-specific antigen does not correlate to other prognostic factors in breast cancer.
    Heyl W; Wolff JM; Biesterfeld S; Schröder W; Zitzelsberger D; Jakse G; Rath W
    Anticancer Res; 1999; 19(4A):2563-5. PubMed ID: 10470195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
    Yu H; Levesque MA; Clark GM; Diamandis EP
    Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oestrogen and progesterone receptors in Nigerian breast cancer: relationship to tumour histopathology and survival of patients.
    Ikpatt OF; Ndoma-Egba R
    Cent Afr J Med; 2003; 49(11-12):122-6. PubMed ID: 15301464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer.
    Yu H; Giai M; Diamandis EP; Katsaros D; Sutherland DJ; Levesque MA; Roagna R; Ponzone R; Sismondi P
    Cancer Res; 1995 May; 55(10):2104-10. PubMed ID: 7538047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-specific antigen and hormone receptor expression in male and female breast carcinoma.
    Kraus TS; Cohen C; Siddiqui MT
    Diagn Pathol; 2010 Sep; 5():63. PubMed ID: 20863373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemical detection of prostate specific antigen expression in human breast carcinoma cells.
    Bodey B; Bodey B; Kaiser HE
    Anticancer Res; 1997; 17(4A):2577-81. PubMed ID: 9252683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of androgen receptor and prostate-specific antigen in breast cancer.
    Narita D; Raica M; Suciu C; Cîmpean A; Anghel A
    Folia Histochem Cytobiol; 2006; 44(3):165-72. PubMed ID: 16977795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of prostate-specific antigen immunoreactivity in breast tumors.
    Diamandis EP; Yu H; Sutherland DJ
    Breast Cancer Res Treat; 1994; 32(3):301-10. PubMed ID: 7532468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of prostate-specific antigen in invasive breast carcinoma and its relationship with routine clinicopathologic parameters.
    Mohammadizadeh F; Ranaee M; Zavareh MH; Faghihi M; Saremi M; Eftekhari M
    Adv Biomed Res; 2012; 1():55. PubMed ID: 23326786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Estrogen and progesterone receptors of primary breast carcinoma and their axillary lymph node metastases--immunohistochemical investigations of routine formalin-fixed paraffin-embedded tissue].
    Schulze MH; Buchmann J
    Zentralbl Gynakol; 2000; 122(2):92-5. PubMed ID: 10721188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers.
    Wernicke AG; Varma S; Greenwood EA; Christos PJ; Chao KS; Liu H; Bander NH; Shin SJ
    APMIS; 2014 Jun; 122(6):482-9. PubMed ID: 24304465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical localization of prostate-specific antigen in benign and malignant breast tissues.
    Howarth DJ; Aronson IB; Diamandis EP
    Br J Cancer; 1997; 75(11):1646-51. PubMed ID: 9184181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate specific antigen (PSA) in breast and ovarian cancer.
    Kucera E; Kainz C; Tempfer C; Zeillinger R; Koelbl H; Sliutz G
    Anticancer Res; 1997; 17(6D):4735-7. PubMed ID: 9494598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.